At the news
? NEUTRALIMPACT 2/10 144 filed May 11, 2026 at 11:38 ET
Director Garen G. Bohlin filed a Form 144 notice of intent to sell 8,700 shares of Collegium Pharmaceutical common stock, valued at approximately $323,491. The sale is planned through Fidelity Brokerage Services LLC and relates to shares acquired via a 2016 option grant.
- Director Garen G. Bohlin filed Form 144 to sell 8,700 shares.
- Estimated sale value: $323,491.
- Shares relate to a 2016 option grant.
- Sale to be executed through Fidelity Brokerage Services LLC.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access